择期肩部手术中阿片类药物初治患者的长期术后阿片类药物使用率及危险因素
基于私人行政索赔数据库的回顾性队列研究(证据等级3),纳入2007至2015年接受择期肩部手术的79287例患者,其中79.5%为阿片类药物初治。阿片初治患者中14.6%在术后180天后仍使用阿片类药物,开放肩袖修复比例最高(20.9%),关节镜盂唇修复最低(9.8%)。酒精滥用史(OR 1.56)、抑郁史(OR 1.46)、焦虑史(OR 1.31)、女性(OR 1.11)及较高Charlson合并症指数(OR 1.02)与长期使用风险相关。
要点
- 择期肩部手术患者中79.5%为阿片类药物初治。
- 阿片初治患者术后180天后仍有14.6%在使用阿片类药物。
- 开放肩袖修复后长期使用比例最高(20.9%),关节镜盂唇修复最低(9.8%)。
核心结论
- 多数患者在择期肩部手术前为阿片类药物初治;但阿片初治患者中约七分之一在术后180天后仍使用阿片类药物。
- 在所有变量中,精神疾病史最显著增加择期肩部手术后长期阿片类药物使用风险。
研究设计与样本
- 回顾性队列研究,证据等级3,对私人行政索赔数据库进行回顾性分析。
- 识别2007年至2015年间接受择期肩部手术的患者79287例。
- 阿片类药物初治定义为索引手术前180天内未开具阿片类药物处方。
- 采用逻辑回归识别预测长期阿片类药物使用的患者变量,长期使用定义为术后180天后仍持续续开阿片类药物。
主要发现
- 研究期间共识别79287例择期肩部手术患者,其中79.5%为阿片类药物初治。
- 阿片初治患者术后阿片类药物使用率随时间下降,14.6%在术后180天后仍使用阿片类药物。
- 术后180天后仍续开阿片类药物比例最高为开放肩袖修复(20.9%),最低为关节镜盂唇修复(9.8%)。
- 酒精滥用史(OR 1.56)、抑郁史(OR 1.46)、焦虑史(OR 1.31)、女性(OR 1.11)及较高Charlson合并症指数(OR 1.02)对阿片初治患者长期阿片类药物使用风险影响最显著。
关键数值与推荐
- 阿片类药物初治:索引手术前180天内未开具阿片类药物处方。
- 长期阿片类药物使用:术后180天后仍持续续开阿片类药物。
- 开放肩袖修复后长期使用比例20.9%,关节镜盂唇修复后9.8%。
- 酒精滥用史OR 1.56,抑郁史OR 1.46,焦虑史OR 1.31,女性OR 1.11,较高Charlson合并症指数OR 1.02。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known regarding the rates and risk factors for long-term postoperative opioid use among opioid-naïve patients undergoing elective shoulder surgery. PURPOSE: To identify (1) the proportion of opioid-naïve patients undergoing elective shoulder surgery, (2) the rates of postoperative opioid use among these patients, and (3) the risk factors associated with long-term postoperative opioid use. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A retrospective review of a private administrative claims database was performed to identify those individuals who underwent elective shoulder surgery between 2007 and 2015. "Opioid-naïve" patients were identified as those patients who had not filled an opioid prescription in the 180 days before the index surgery. Within this subgroup, we tracked postoperative opioid prescription refill rates and used a logistic regression to identify patient variables that were predictive for long-term opioid use, which we defined as continued opioid refills beyond 180 days after surgery. Results were reported as odds ratios (ORs). RESULTS: Over the study period, 79,287 patients were identified who underwent elective shoulder surgery, of whom 79.5% were opioid naïve. Among opioid-naïve patients, the rate of postoperative opioid use declined over time, and 14.6% of patients were still using opioids beyond 180 days. The greatest proportion of opioid-naïve patients still filling opioid prescriptions beyond 180 days postoperatively was seen after open rotator cuff repair (20.9%), whereas arthroscopic labral repair had the lowest proportion (9.8%). Overall, a history of alcohol abuse (OR 1.56), a history of depression (OR 1.46), a history of anxiety (OR, 1.31), female sex (OR, 1.11), and higher Charlson Comorbidity Index (OR 1.02) had the most significant influence on the risk for long-term opioid use among opioid naïve patients. CONCLUSIONS: Most patients were opioid naïve before elective shoulder surgery; however, among opioid-naïve patients, 1 in 7 patients were still using opioids beyond 180 days after surgery. Among all variables, a history of mental illness most significantly increased the risk of long-term opioid use after elective shoulder surgery.
引用
- Leroux TS, Saltzman BM, Sumner SA, et al. Elective Shoulder Surgery in the Opioid Naïve: Rates of and Risk Factors for Long-term Postoperative Opioid Use. Am J Sports Med. 2019. PMID: 30943077. doi:10.1177/0363546519837516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。